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Type 2 diabetes mellitus increases the risk of dementia and neuronal dysfunction may occur years before perceptible cognitive
decline. We aimed to study the impact of type 2 diabetes on brain activation during memory encoding in middle-aged people,
controlling for age, sex, genes, and early-shared environment. Twenty-two twin pairs discordant for type 2 diabetes mellitus (mean
age 60.9 years) without neurological disease were recruited from the Australian Twin Registry (ATR) and underwent functional
magnetic resonance imaging (fMRI) during a memory encoding task, cognitive tests, and structural MRI. Type 2 diabetes was
associated with significantly reduced activation in left hemisphere temporoparietal regions including angular gyrus, supramarginal
gyrus, and middle temporal gyrus and significantly increased activation in bilateral posteriorly distributed regions. These findings
were present in the absence of within-pair differences in standard cognitive test scores, brain volumes, or vascular lesion load.
Differences in activationweremore pronounced amongmonozygotic (MZ) pairs, withMZ individuals with diabetes also displaying
greater frontal activation. These results provide evidence for preclinical memory-related neuronal dysfunction in type 2 diabetes.
They support the search for modifiable later-life environmental factors or epigenetic mechanisms linking type 2 diabetes and
cognitive decline.
1. Introduction
Type 2 diabetes mellitus is associated with an increased inci-
dence of dementia in late life [1]. People with onset of type 2
diabetes inmiddle age have a greater risk of a future dementia
than those with late onset disease [2] possibly because of
longer exposure. Dementia, particularly Alzheimer’s demen-
tia (AD), is associated with changes in brain function
that may precede overt structural brain abnormalities or
cognitive deficits by several years [3]. Functional magnetic
resonance imaging (fMRI) studies demonstrate alterations in
the activity of distributed neural networks serving memory
function in patients with early AD and its precursor state
of mild cognitive impairment (MCI) and even in otherwise
asymptomatic individuals at risk for AD [3]. In recent
resting state fMRI studies, patients with type 2 diabetes
displayed reduced functional connectivity [4] and white
matter integrity [5] in the default mode network compared
with controls. Cortical activation during a cognitive task may
also be an important biomarker of future dementia in older
people [6] and in those with type 2 diabetes [7]. Episodic
encoding impairment from mesial temporal dysfunction is
the hallmark early feature of cognitive decline in MCI and
AD [6]. However, such an implicit encoding paradigm that
provides a strong measure of mesial temporal activation [8]
has not been used in the setting of type 2 diabetes andmay be
highly suitable to test the links between diabetes and demen-
tia.
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Genetics and early-shared environment play important
roles in determining later-life brain structure [9, 10], cog-
nition [11], and fMRI activation [12]. Therefore, accounting
for confounding by genes and early-shared environment is
particularly important when isolating the effects of type 2
diabetes on the earliest neural signs of impending cogni-
tive decline, and this has not been achieved in the few
previous functional imaging studies in people with type 2
diabetes. Studying cotwins who are discordant for type 2
diabetes provides powerful control for such confounders.
Thus, we compared fMRI activation during implicit memory
encoding, as well as cognitive function and brain structure
within middle-aged twin pairs discordant for type 2 diabetes.
We hypothesized that diabetes-affected individuals would
have altered brain activation during a memory encoding
paradigm, poorer cognitive function, and altered brain struc-
ture compared to their cotwins without diabetes.
2. Methods
2.1. Sample. The sample was derived from the Australian
Twin Registry (ATR), a nation-wide volunteer agency funded
by the Australian National Health and Medical Research
Council (NHMRC). We invited participants (monozygotic
and dizygotic) with type 2 diabetes (aged ≥50 years) and
their discordant pairs without diabetes from a cohort in
which type 2 diabetes was confirmed with a high degree of
accuracy by a diabetologist [13]. Fasting finger-prick glucose
levels was used as an additional measure of phenotype
validation in our study, and fasting glucose <7.0mmol/L
was used to confirm absence of diabetes in the cotwin [14];
HbA1c levels were not available. Zygosity was established
by the ATR using standard responses to questions shown
to have 95% accuracy for such a purpose [15]. Exclusion
criteria were a history of significant neurological disease
including stroke/TIA, seizures, dementia, Parkinson’s disease,
and severe head trauma. This study was approved by the
Monash University Human Research Ethics Committee and
written informed consent was obtained.
2.2. MRI Acquisition. MRI scanning was performed on a
single Siemens Trio Tim 3-Tesla (3T) MRI at the Murdoch
Childrens Research Institute, Melbourne, Australia. Struc-
tural MRI (sMRI) sequences: these included high resolution
T1-weighted images (0.9mm isotropic, TR =1800ms, TE =
2.2ms, Flip Angle = 9∘, and FOV = 230) and T2/FLAIR
images (1mm isotropic, TR = 6000ms, TE = 405ms, and
FOV = 256); fMRI sequences: these included echoplanar
imaging (EPI) sequence (TR = 3000ms, TE = 40ms, slice
thickness = 3mm no gap, FOV = 210, and N slices = 39)
with whole brain coverage using an incidental memory task,
based on a well-established mixed-design [16]. The person
administering the task could not be completely blinded
to diabetes status but was completely unaware of specific
study hypotheses. The fMRI paradigm was delivered via
Presentation software (Neurobehavioral Systems Inc.). The
experiment comprised seven cycles of task and rest. For
each cycle, three blocks of ten stimuli (words, simple line
drawings, or fixation, presented for three seconds each) were
shown in the centre of the screen. For blocks of words,
participants were instructed to indicate via a button press
whether the item was living or nonliving, to encourage
encoding via a semantic route, which improves encoding
[17]. Similarly, the objects depicted included animate and
inanimate items and participants indicated whether these
were living/nonliving via button press. There was an equal
number of living and nonliving items within each block,
presented in fixed random order. The resting block showed
a fixation cross that varied in size. Participants indicated via
button press whether the cross was large or small and were
given practice outside the scanner before the session to ensure
that they understood the task requirements. Each block lasted
30 seconds, giving a total session length of ten minutes
and thirty seconds. The design of our experiment controlled
for unwanted effects of motor response, decision-making,
and visual stimulus. Participants were told that the task was
designed to examine brain activity for different stimuli types
and were not advised to memorize the items. They were
not informed in advance of the later recognition memory
test. The incidental nature of the memory encoding phase
avoids directing the participant to use a particular strategy,
whichmight account for interindividual differences in neural
response. Thirty minutes after fMRI acquisition, participants
were presented with a surprise recognition memory task
on a laptop computer with previously presented stimuli
mixed with 35 previously unseen items (“foils”). In this
phase, participants were instructed to respond whether they
remembered seeing the stimulus during the scanning sessions
or whether it was new. Items correctly recognized in this
test were assumed to reflect accurate encoding and were
considered as outcomes in subsequent paired fMRI analyses.
2.3. Cognitive Assessment. These tests were performed after
fMRI and were selected for their sensitivity to early cognitive
decline in dementia.We screened general intellectual abilities
with the National Adult Reading Test-Revised (NART-R)
[18]; basic attention processing skills with theMental Control
and Digit Span subtests from the Wechsler Memory Scale
3 (WMS3) [19]; Memory with Hopkins Verbal Learning
Test-Revised [20]; short (5 minute) recall for delayed Rey-
Osterrieth Complex Figure [20]; Paired Associate Learning
subtest from the Wechsler Memory Scale (WMS-1). In addi-
tion, we used the Cambridge Neuropsychological Automated
Test Battery (CANTAB) [21] to measure basic and choice
reaction time and visual Paired Associate Learning (VPAL), a
taskwhich is highly sensitive to the early detection ofAD [22].
Paired 𝑡-tests were used to compare cognitive scores between
cotwins.
2.4. Image Analyses. Preprocessing was conducted blind to
age, sex, diabetes status, clinical or cognitive measurements,
and zygosity.
fMRI Analysis. We analyzed fMRI memory blood oxygen-
level dependent (BOLD) activation with FSL 4.1.4
(FMRIB Software Library, The University of Oxford) using
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the standard analytic pipeline. Following brain extraction
with BET [23], linear registration was performed using
T1 images. EPI scans of each subject were motion and
slice-timing corrected, normalized to the standard Montreal
Neurological Institute (MNI152) template in stereotaxic
coordinate space, and smoothed using a 5mm isotropic
Gaussian kernel. After high-pass filtering (cut-off 100 s),
data were convolved using Gamma function with temporal
derivative and analyzed using a general linear model. We
used event-related analyses to compare encoding-related
activation responses for individual stimuli (drawings and
words) that were correctly recognized versus activation
during the baseline condition (cross-hairs) for each
participant. Group-level analysis across the whole brain
was first performed to characterize the pattern of activation
during memory encoding in the T2DM affected and
unaffected twins using 𝑧 > 2.3 and cluster family-wise error
(FWE) corrected 𝑝 < 0.05. Where stated, we controlled for
relevant health-related variables (e.g., waist circumference)
by entering data in FSL during higher-level group analyses.
The study hypotheses were tested by first examining
differences in activation across the whole brain, within
twin pairs by paired-𝑡 test of the contrast images. We also
used mesial temporal region-of-interest analysis to examine
BOLD activation within the hippocampi based on an in-
house hippocampal mask generated by the average of manual
segmentation of the hippocampi in the 22 pairs, as well
as hippocampal and parahippocampal masks derived from
an automated anatomic labelling scheme. Standard analyses
using the general linear model were first conducted in the
whole sample and then repeated after stratifying for zygosity
and controlling for sex (except among MZ), history of
hypertension, and waist circumference by including them as
variables of no interest. We additionally explored the rela-
tionship of duration of diabetes and waist circumference on
regional activation among those with type 2 diabetes alone,
controlling for age, sex, and hypertension. This regression
analysis was performed on a voxelwise basis, across the whole
brain, corrected formultiple comparisons (𝑍 > 2.3, corrected
(cluster) 𝑝 = 0.05). A final, exploratory, conjunction analysis
using the minimum statistic [23] was used to examine
whether activation differences between discordant pairs were
similar for monozygotic and dizygotic twins.
sMRI Analysis. An optimized voxel-based morphometry
(VBM) method was implemented in statistical parametric
mapping software version 8 (SPM 8, Functional Imaging
Laboratories, Institute of Neurology, London) [24]. Auto-
mated segmentation of brain from nonbrain structures was
conducted followed by coregistration of the brains of all
participants to the MNI152 template. VBM detects changes
in the regional concentration of gray matter after correcting
for global differences in brain shape. The optimized method
includes recursive segmentation and spatial normalization
and a modulation step to allow comparison of tissue vol-
umes. For region-of-interest analysis, hippocampal bound-
aries were identified according to previously defined and val-
idated anatomical landmarks and manually segmented by a
single expert [25]. We derived whole brain gray matter, white
matter, and hippocampal volumes using in-house voxel-
counting algorithms. Paired comparison of global volumes
was followed by paired voxelwise comparison of regional
gray and white matter distribution, adopting a family-wise
error (FWE) corrected 𝑝 < 0.05. In addition, restricted
paired region-of-interest (ROI) comparisons were made by
applying the hippocampal mask derived from the Automated
Anatomical Labelling AAL atlas [26].
Cerebrovascular Lesions. All images were reviewed by two
stroke experts (Thanh Phan, Velandai Srikanth) to iden-
tify brain infarcts defined as a hypointense lesion with a
hyperintense rim on FLAIR measuring greater than 3mm.
WMLweremanually segmented on FLAIR images by a single
trained expert using established in-house methods with high
test-retest reliability (intraclass correlation coefficient, ICC
0.98; 95% CI; 0.97–0.99) [27].
2.5. Other Measurements and Analyses. Standardized, struc-
tured questionnaires were used to record educational qual-
ifications, self-reported medical history including hyperten-
sion, ischemic heart disease, stroke, hyperlipidemia, smok-
ing, alcohol consumption, and prior head injury, medication
use, ameasure of currentmoodwith theGeriatricDepression
Scale (GDS) [28], and age of onset of diabetes. Resting arm
blood pressure, waist and hip circumferences, height, and
weight were obtained using standardized protocols.
3. Results
Sample characteristics are provided in Table 1. There were
22 discordant twin pairs with mean age of 60.9 years (SD
6.7), of whom 8 pairs were monozygotic (MZ, mean 60.6
years; SD 7.5) and 14 pairs were dizygotic (DZ, mean 61.5
years; SD 5.6). Overall duration of diabetes in affected
individuals was 10.9 years (SD 9.9). In paired comparisons,
those with type 2 diabetes had higher fasting blood glucose
levels, waist circumference (hence weight), and self-reported
frequency of hypertension and were more likely to be on
cholesterol and blood pressure lowering medication than
their cotwin (all 𝑝 < 0.05). Among those with diabetes,
most (20/22, 91%) were on oral antidiabetes medication
and few (4/22, 18%) were on insulin. Five (23%) people
reported sensory symptoms in their lower extremities, and
four (18%) reported visual problems; all four cases were tested
prior to scanning and confirmed as being able to view the
in-scanner stimuli satisfactorily. Individuals with diabetes
among the MZ group had greater mean waist circumference
(114.3 cm versus 102.8 cm; 𝑝 = 0.009) than their counterparts
among the DZ group but showed similar mean fasting
glucose (7.4mmol/L versus 6.7mmol/L; 𝑝 = 0.28), levels
of all other clinical/demographic variables, and duration of
diabetes (data not shown). No participant reported other
serious neurological disorders and all were independently
living in the community.
3.1. Cognitive Function. There were no significant within-
pair differences in predicted full scale intelligence quotient
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Table 1: Sample characteristics (22 discordant twin pairs).
Type 2 diabetes
Mean (SD) or 𝑛 (%)
No diabetes
Mean (SD) or 𝑛 (%) 𝑝 value
a
Mean age (years) 59.5 (5.3) 59.5 (5.3)
Male sex 12 (55%) 8 (36%) 0.38
Years of education (years) 12.9 (4.8) 12.8 (5.3) 0.88
Fasting glucose (mmol/L) 7.0 (1.5) 5.7 (0.8) 0.02
Hypertension 14 (67%) 6 (28%) 0.04
Ischemic heart disease 2 (9%) 0 (0%) 0.50
Hypercholesterolemia 12 (54%) 11 (50%) 0.98
Ever-smoking 12 (57%) 9 (41%) 0.45
Systolic blood pressure (mmHg) 151 (18.1) 142 (17.9) 0.05
Diastolic blood pressure (mmHg) 83.8 (11.6) 82.9 (8.5) 0.86
Waist (cm) 107.2 (10.6) 96.6 (16.2) 0.004
Height (cm) 164.9 (21.4) 166.4 (10.9) 0.78
Weight (kg) 93.5 (14.9) 84.1 (18.9) 0.03
Mood score (GDS) 2.7 (2.6) 2.2 (2.9) 0.45
NART-R FSIQ 107.9 (8.9) 107.8 (8.5) 0.93
HVLT delayed recall 9.0 (2.5) 9.8 (1.9) 0.25
HVLT recognition 11.5 (0.7) 11.2 (1.1) 0.25
Rey complex figure copy 34.7 (1.8) 34.7 (2.3) 0.94
Rey complex figure delayed recall 19.4 (6.1) 19.5 (6.5) 0.94
WMS3 mental control 25.5 (6.1) 25.3 (4.7) 0.88
WMS3 digit span total 18.5 (4.2) 18.6 (3.9) 0.83
PAL total errors (raw) 27.9 (30.1) 28.2 (31.5) 0.96
SRT correct latency (mean) 275.1 (62.4) 258.2 (43.5) 0.21
Total hippocampal volume (mL) 4.5 (0.5) 4.5 (0.6) 0.99
Gray matter volume (mL) 635.7 (63) 644.2 (62) 0.59
White matter volume (mL) 461.4 (59) 468.6 (52) 0.55
White matter lesion volume (mL) 4.6 (2.0) 5.1 (3.3) 0.31
MRI infarcts 0 (0) 0 (0)
Insulin therapy 4 (18%) 0 (0) <0.001
Oral antidiabetic agents 20 (91%) 0 (0) <0.001
Blood pressure agents 18 (82%) 7 (32%) <0.001
Cholesterol lowering agents 17 (77%) 5 (23%) <0.001
Duration of diabetes (years) 10.1 (9.7) —
a
𝑝 for within-pair comparisons using paired 𝑡-test (for continuous variables) and McNemar’s test (for categorical variables).
GDS: Geriatric Depression Scale; NART-R: National Adult Reading Test-Revised; HVLT: Hopkins verbal learning test; WMS3:Wechsler memory scale version
3; FSIQ: full scaled intelligence quotient; SRT: simple reaction time from the CANTAB; PAL: paired associates learning test from the CANTAB; SD: standard
deviation; MRI: magnetic resonance imaging.
(NART-R FSIQ) or any other cognitive test either in the
whole sample or within zygosity subgroups (Table 2). There
were no significant within-pair differences in the number
of correctly recognized (i.e., encoded) items administered
during the fMRI scanning session.
3.2. fMRI BOLD Activation. To confirm that the paradigm
performed in the expected manner, we conducted a group
analysis across the entire sample of twins without diabetes
(i.e., ND). The analysis was performed only in ND because
this group should demonstrate normal BOLD signal change
in response to the task as well as a typical pattern of
suprathreshold activation. As expected, BOLD activation for
correctly encoded items during the incidental memory task
was observed in the mesial temporal region as well as a
distributed network of brain regions (Figure 1: 𝑍 > 2.3 and
corrected cluster level threshold of 𝑝 = 0.05).
3.2.1. Within-Pair Comparisons among Discordant Twins.
Reduced activation during encoding was found in type
2 diabetes in the following regions (Figure 2 (blue areas)
and Table 3): (a) all pairs: left hemisphere temporoparietal
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Table 2: Cognitive scores and brain volumes stratified by zygositya.
Cognitive score
Monozygotic (8 pairs) Dizygotic (14 pairs)
Type 2 diabetes
Mean (SD)
No diabetes
Mean (SD)
Type 2 diabetes
Mean (SD)
No diabetes
Mean (SD)
NART-R FSIQ 108.9 (8.7) 107.6 (9.9) 107.4 (9.3) 107.9 (7.9)
HVLT delayed recall 9.4 (2.1) 9.6 (1.7) 8.9 (2.7) 9.9 (2.0)
HVLT recognition 11.9 (0.4) 11.4 (1.1) 11.3 (0.8) 11.1 (1.1)
Rey complex figure copy 34.2 (2.4) 35.6 (0.7) 35.0 (1.4) 34.1 (2.7)
Rey complex figure delayed recall 19.3 (5.7) 18.5 (7.0) 19.5 (6.6) 20.1 (6.4)
WMS3 mental control 27.3 (7.2) 26.2 (5.8) 24.4 (5.4) 24.7 (4.1)
WMS3 digits total 19.6 (5.3) 19.1 (4.5) 17.8 (3.4) 18.4 (3.3)
SRT correct latency (mean) 260.9 (56.9) 273.9 (56.3) 283.1 (65.9) 249.2 (33.4)
PAL total errors (raw) 27.6 (25.2) 34.4 (41.5) 28.0 (33.6) 24.7 (25.3)
fMRI task, word errors 29.5 (16.4) 28.8 (19.8) 22.6 (15.7) 21.4 (12.2)
fMRI task, drawing errors 18.5 (14.5) 14.7 (10.9) 21.6 (14.4) 22.0 (13.7)
Total hippocampal volume (mL) 4.8 (0.4) 4.7 (0.6) 4.3 (0.5) 4.4 (0.6)
Gray matter volume (mL) 633.7 (53) 664.6 (78) 641.9 (70) 631.0 (49)
White matter volume (mL) 470.2 (48) 494.4 (56) 463.6 (63) 461.8 (45)
White matter lesion volume (mL) 5.2 (2.9) 6.2 (4.8) 4.3 (1.5) 4.5 (2.2)
NART-R: national adult reading test-revised; HVLT: Hopkins verbal learning test; WMS3: Wechsler memory scale version 3; FSIQ: full scaled intelligence
quotient; SRT: simple reaction time from the CANTAB; PAL: paired associates learning test from the CANTAB; SD: standard deviation; fMRI: functional
magnetic resonance imaging.
aNone of the comparisons above reached statistical significance of 𝑝 < 0.05.
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Figure 1: BOLD-fMRI activation during incidental memory encod-
ing (whole-brain analysis, 𝑍 > 2.3, FWE corrected) in individuals
without diabetes.
structures including angular gyrus, supramarginal gyrus,
and middle temporal gyrus; (b) MZ pairs: left hemisphere
anterior prefrontal cortex; (c) DZ pairs: left hemisphere
temporoparietal structures includingmiddle temporal gyrus,
angular gyrus, and supramarginal gyrus. Greater activation
during encoding was found in type 2 diabetes in the fol-
lowing regions (Figure 2 (red areas) and Table 4): (a) all
pairs: bilateral superior parietal lobule and precuneus, right
hemisphere inferior parietal lobule, and left occipital cortex
extending to fusiform and cuneus; (b) MZ pairs: bilateral
widespread network spanning parietal, occipital cortices and
middle frontal gyrus, and left anterior prefrontal cortex; (c)
DZ pairs: bilateral precuneus, left fusiform gyrus and cuneus,
R L
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x = 69 y = 32 z = 49
x = 48 y = 37 z = 63
x = 69 y = 32 z = 49
Figure 2: BOLD-fMRI activation differences within twin pairs
discordant for type 2 diabetes. Results are displayed in all pairs
(22 pairs, first row), monozygotic pairs (8 pairs, second row), and
dizygotic pairs (14 pairs, last row).Blue: areas of decreased activation
in type 2 diabetes mellitus. Red: areas of increased activation in
type 2 diabetes mellitus. 𝑥, 𝑦, and 𝑧 refer to Montreal Neurological
Institute (MNI) voxel coordinates for the selected slices.
and right superior and inferior parietal lobule. No within-
pair differences were found in task-related BOLD activation
for the subject-specific hippocampal template ROI analysis
and in the ROI analysis encompassing both hippocampus
and parahippocampal gyrus. In an exploratory conjunction
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Table 3: Regions (and 𝑥, 𝑦, and 𝑧 coordinates) associated with
reduced activation in type 2 diabetes.
All (22 pairs)
Region Hemisphere 𝑥 𝑦 𝑧 𝑍 score 𝑘
Middle temporal gyrus L −48 −66 20 4.64 401
Angular gyrus L −36 −66 34 3.36
Angular gyrus L −40 −68 36 3.35
Middle temporal gyrus L −48 −64 32 3.29
Inferior parietal lobule L −50 −46 26 3.22
Middle temporal gyrus L −46 −72 30 3.08
Middle temporal gyrus L −52 −36 −8 4.39 399
Middle temporal gyrus L −62 −46 −8 4.26
Middle temporal gyrus L −62 −36 −12 3.43
Middle temporal gyrus L −64 −34 −16 3.41
Middle temporal gyrus L −56 −40 4 3.32
Superior temporal gyrus L −62 −44 6 3.3
MZ (8 pairs)
Region Hemisphere 𝑥 𝑦 𝑧 𝑍 score 𝑘
Medial frontal gyrus L −10 58 4 4.29 270
Medial frontal gyrus L −6 48 18 4.27
Superior frontal gyrus L −12 62 8 4.2
Medial frontal gyrus L −6 48 14 4.16
Medial frontal gyrus L −6 54 20 4.12
DZ (14 pairs)
Region Hemisphere 𝑥 𝑦 𝑧 𝑍 score 𝑘
Middle temporal gyrus L −60 −48 −10 3.71 421
Middle temporal gyrus L −52 −36 −10 3.5
Middle temporal gyrus L −54 −46 8 3.42
Middle temporal gyrus L −56 −36 −8 3.32
Middle temporal gyrus L −60 −32 −10 3.3
Middle temporal gyrus L −64 −34 −16 3.09
Middle temporal gyrus L −48 −66 22 3.8 307
Angular gyrus L −38 −66 34 3.38
Middle temporal gyrus L −38 −68 30 3.34
Supramarginal gyrus L −46 −52 34 3.1
Middle temporal gyrus L −42 −68 30 3.04
Middle temporal gyrus L −46 −72 30 3.02
Covariates include gender (except inMZ comparisons), waist circumference,
and history of hypertension.
MZ: monozygotic; DZ: dizygotic.
𝑥,𝑦, and 𝑧 refer toMontrealNeurological Institute voxel coordinates; regions
are based on the Talairach Daemon; 𝑘: peak voxel cluster; L: left hemisphere.
All comparisons are within twin pairs and corrected for family-wise error
(FWE) threshold of 0.05.
analysis, small areas of overlap were detected between MZ
andDZ comparisons for reduced activation in diabetes in the
left precuneus and middle temporal gyrus and for increased
activation in diabetes in bilateral superior parietal and lateral
occipital cortices and the left precentral gyrus. However these
clusters did not survive correction for multiple comparisons
at a cluster level significance of 𝑝 = 0.05.
3.2.2. Duration of Type 2 Diabetes, Waist Circumference, and
BOLD Activation. Duration of type 2 diabetes was positively
correlated with left hemisphere BOLD activation in anterior
Table 4: Regions associated with increased activation in type 2
diabetes.
All (22 pairs)
Region Hemisphere 𝑥 𝑦 𝑧 𝑍 score 𝑘
Precuneus R 22 −76 50 4.85 3641
Inferior parietal lobule R 32 −82 2 4.7
Inferior parietal lobule R 36 −54 48 4.59
Superior parietal lobule R 28 −72 50 4.49
Superior parietal lobule R 36 −56 58 4.36
Cuneus R 30 −82 6 4.34
Fusiform gyrus L −46 −74 −12 4.88 1642
Cuneus L −2 −84 16 4.34
Cuneus L −16 −90 36 4.22
Middle occipital gyrus L −54 −68 −4 4.2
Middle occipital gyrus L −36 −86 6 4.13
Middle occipital gyrus L −46 −82 18 4.12
Superior parietal lobule L −28 −64 56 4.84 540
Superior parietal lobule L −30 −64 50 4.32
Superior parietal lobule L −24 −62 56 4.08
Precuneus L −20 −60 54 4.03
Precuneus L −26 −70 48 3.6
Superior parietal lobule L −26 −70 52 3.6
MZ (8 pairs)
Region Hemisphere 𝑥 𝑦 𝑧 𝑍 score 𝑘
Precuneus L −4 −70 44 4.75 5640
Superior parietal lobule R 10 −66 62 4.66
Cingulate gyrus R 4 −44 38 4.58
Precuneus R 2 −48 40 4.58
Inferior parietal lobule R 46 −44 60 4.56
Superior parietal lobule R 34 −60 60 4.53
Angular gyrus L −54 −60 42 4.6 1561
Inferior parietal lobule L −52 −50 44 4.5
Inferior parietal lobule L −38 −54 48 4.47
Inferior parietal lobule L −50 −40 44 4.46
Inferior parietal lobule L −52 −54 44 4.4
Inferior parietal lobule L −46 −44 50 4.37
Medial frontal gyrus R 24 4 50 4.38 748
Medial frontal gyrus R 32 −4 58 4.28
Middle frontal gyrus R 30 −4 54 4.11
Middle frontal gyrus R 32 6 58 3.83
Middle frontal gyrus L −38 32 18 4.39 719
Middle frontal gyrus L −28 −2 54 4.06
Middle frontal gyrus L −30 0 60 3.94
Middle frontal gyrus L −38 54 −16 4.89
Precentral gyrus L −24 24 34 3.78
Precentral gyrus L −24 −12 54 3.74
Precentral gyrus L −20 −12 54 3.74
Superior frontal gyrus L −32 60 −14 4.17
Superior frontal gyrus L −32 62 −18 3.87
Middle frontal gyrus L −34 40 −16 3.38 328
Inferior parietal lobule L −60 −30 38 4.28
Inferior parietal lobule L −60 −26 32 3.9
Inferior parietal lobule L −66 −32 30 3.78 284
Inferior parietal lobule L −64 −28 30 3.7
Inferior parietal lobule L −62 −36 18 3.38
Inferior parietal lobule L −64 −36 24 3.23
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Table 4: Continued.
DZ (14 pairs)
Region Hemisphere 𝑥 𝑦 𝑧 𝑍 score 𝑘
Middle occipital gyrus L −28 −92 24 4.12 857
Cuneus L −24 −92 28 4.07
Cuneus L −16 −88 36 4.05
Middle occipital gyrus L −32 −88 2 3.88
Middle occipital gyrus L −24 −88 18 3.78
Middle occipital gyrus L −34 −92 4 3.71
Fusiform gyrus L −48 −74 −12 4.36 421
Middle occipital gyrus L −54 −68 −4 3.63
Precuneus R 22 −76 50 3.81
Precuneus R 26 −72 52 3.74 400
Middle occipital gyrus R 32 −78 24 3.59
Superior parietal lobule R 26 −66 48 3.55
Middle occipital gyrus R 34 −84 4 3.52
Precuneus R 32 −74 40 3.34
Superior parietal lobule R 34 −56 58 3.65
Inferior parietal lobule R 36 −56 48 3.51 276
Inferior parietal lobule R 36 −52 40 3.09
Superior parietal lobule R 20 −54 64 2.95
Superior parietal lobule R 26 −50 64 2.76
Inferior parietal lobule R 36 −44 46 2.57
Covariates include gender (except inMZ comparisons), waist circumference,
and history of hypertension.
MZ: monozygotic; DZ: dizygotic.
𝑥,𝑦, and 𝑧 refer toMontrealNeurological Institute voxel coordinates; regions
are based on the Talairach Daemon; 𝑘: peak voxel cluster; L: left hemisphere;
R: right hemisphere.
All comparisons are within twin pairs and corrected for family-wise error
(FWE) threshold of 0.05.
prefrontal, posterior cingulate, and extrastriate cortices; right
hemisphere activation in the inferior parietal, precentral
gyrus, and inferior frontal operculum and bilaterally in the
precuneus and angular gyrus. Waist circumference was neg-
atively correlated with activation in left hemisphere regions
including the superior and inferior frontal gyri, superior
occipital gyrus, precuneus, and middle temporal gyrus.
3.3. Differences in Brain Volumes and Vascular Lesions.
Adopting a whole brain VBM approach, there were no sig-
nificant within-pair voxel differences for total gray, white,
hippocampal, and WML volumes either in the whole sample
or after stratifying for zygosity. Targeted region-of-interest
(ROI) comparisons also showed no between-pair voxel dif-
ferences in the hippocampi.
4. Discussion
Using a discordant pairs twin design, we found significant
within-pair differences in brain BOLD-fMRI activation dur-
ing memory encoding in middle-aged cotwins discordant for
type 2 diabetes, in the notable absence of differences in highly
sensitive measures of cognitive function or brain volumes.
Type 2 diabetes was associatedwith reduced BOLDactivation
in the left temporoparietal regions, while displaying increased
activation in predominantly posterior cortical networks.This
increased posterior activation was particularly pronounced
in MZ individuals with diabetes who also displaying greater
frontal activation. Longer duration of diabetes was associated
with greater activation, while greater waist circumferencewas
associated with reduced activation. These findings provide
strong support for the notion that type 2 diabetes has an
adverse effect on neuronal function long before frank clinical
decline is detected.
The principal strength of our study is the cotwin design
supported by careful phenotyping of diabetes, the use of
advanced brain imaging methods, and extensive cognitive
testing. Most previous studies using fMRI in type 2 diabetes
have examined activation differences in resting state [4, 29].
The use of fMRI to examine memory encoding has received
little attention despite growing concern about the cognitive
sequelae of diabetes in the elderly. In a recent fMRI study
performed during active memory task comparing people
with type 2 diabetes (𝑛 = 22, mean age 56 years) and con-
trols (29, mean age 52.7 years) [7], diabetes was associated
with impaired task-related deactivation of the default mode
network and reduced activation of the dorsolateral prefrontal
cortex.Their task differed fromours by requiring participants
to actively remember an association between object and
feature (colour) during the encoding phase which results
in stronger prefrontal and lower mesial temporal activation
[8]. In contrast, given the potential links between type 2
diabetes and Alzheimer’s dementia, we focused our design
by employing an incidental-encoding paradigm that reliably
activates the mesial temporal lobes. We examined a slightly
older sample (mean age ∼60 years) and by virtue of our
twin design obtained excellent control for age, genes, and
markers of intellectual achievement (years of education and
IQ scores on the NART-R), reflecting early-shared environ-
ment.
We propose that our data represent evidence of early
alteration of functional mnemonic networks, but longitu-
dinal data are required to confirm this interpretation. The
increases in task-related BOLD activation may reflect a
compensatory phenomenon to preserve function in the early
stages of neuronal dysfunction or neurodegeneration in task-
relevant regions. Accordingly, older patients with insulin
resistance or type 2 diabetes show more diffuse regional
glucose metabolism during memory encoding compared
with cognitively normal older adults [30]. A recent study
of 12 people with type 2 diabetes found greater left parietal
and right dorsolateral prefrontal activation during high-
load working memory performance compared with unre-
lated controls [31]. Greater levels of hyperactivation were
associated with poorer disease control, providing support
for the general principle that an early neural compensatory
mechanismmay occur in cognitively intact patients with type
2 diabetes. In contrast to our study, this study addressed
higher-order executive function compensation rather than
episodic memory per se and so the specific patterns of
fMRI activation cannot be compared directly. Nevertheless,
similar compensatory increases in brain activation in regions
other than primary memory encoding networks are well-
recognized phenomena in high-performing older adults [32]
and in cognitively normal people at a higher risk of dementia
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such as carriers of apolipoprotein E4 (ApoE4) [33] or the
presenilin 1 mutation [34]. Such increases in activation may
also reflect a pathological loss of inhibition preceding deacti-
vation [35] or purely be a physiological response to decreased
activation in other regions not necessarily due to neuronal
loss [36].
An interesting observation in our study was the greater
BOLD activation among MZ individuals with diabetes com-
pared with their cotwin than that observed in DZ pairs, in
the presence of complete control for genetic variation and
strong control for early-shared environment. Since frontal
activation during a cognitive task has high heritability [12],
it is conceivable that the presence of type 2 diabetes interacts
with as yet undefined genotypes to influence activation in the
frontal cortex. These results raise the interesting possibility
that adult age environmental, lifestyle, or epigenetic factors
may influence diabetes-related neuronal loss/dysfunction.
Central obesity, which is closely related to adverse lifestyle,
was greater amongMZ individuals with diabetes in our study
and is known to be associated with a greater risk of dementia
[37] and brain atrophy [38], and its proinflammatory or
metabolic effects on the brain may conceivably explain the
stronger findings amongMZ diabetics. However these results
did not survive correction for multiple testing, and therefore
any interpretation is speculative. The regions of increased
activation are similar to those found in other studies in
which compensation for early cognitive decline is mooted.
Indeed, there was also evidence of reduced activation in the
diabetic twin in functionally relevant areas (e.g., left middle
temporal gyrus). The reduction of temporal lobe activation
and concomitant increased activation in putative compen-
satory networks supports speculation that cognitive change
experienced by older people with diabetes may be caused by
neurodegeneration. An exploratory uncorrected conjunction
analysis showed overlap in activation patterns in MZ and DZ
twin pairs compared to their ND cotwins in these regions.
This suggests that this pattern of decreased and increased
activation is specifically related to the neural consequences
of diabetes and therefore may represent a neural biomarker
of incipient cognitive decline.We emphasise that this analysis
requires replication in larger samples.
In addition to the common areas of activation or deac-
tivation in MZ and DZ twins within the broad network
of brain regions associated with memory encoding, there
were a number of regions of activation that differed between
MZ and DZ twins. We cannot exclude a role for glucose
in the MZ-DZ differences even though blood glucose was
the same between MZ and DZ diabetics, because we did
not have data for HbA1c, a marker of longer-term glucose-
control.There are potentially several other nongenetic factors
of interest that we were unable to measure that could also
explain our findings. Apart from white matter lesions, we did
not have any objective measures of cerebral microvascular
structure and function, aortic stiffening, physical activity,
and dietary patterns. There is emerging understanding of the
role of epigenetic modification of neuronal gene expression
in the ageing brain and consequent impairment of neu-
ronal function [39], and it would be of interest to study
whether type 2 diabetes is associated with such changes. A
recent study has demonstrated differences in histone deacety-
lase expression in brain between people with and without
T2D, and these differences correlate with altered expression
of synaptic proteins and consequent synaptic dysfunction
[40].
There are limitations to our study that may be addressed
in future work. The current analysis is cross-sectional, and
hence causal links cannot be proven. BOLD activation also
does not clearly separate the effects of changes in blood flow
from actual neuronal metabolism but to counter this we
excluded those with stroke, and there was no within-pair
difference in the volume of white matter lesions. The effect
of cerebrovascular lesions may however become more potent
with advancing age and severity of type 2 diabetes and a lon-
gitudinal and/or older cohort would help answer these ques-
tions. Further research using additional and concurrent func-
tional images methodologies (e.g., Arterial Spin Labelling,
hypercapnia experiments, and neuronal metabolism using
FDG-PET)may assist in further disentangling neurovascular
mechanisms underlying altered cortical function in type 2
diabetes. Furthermore, cerebrovascular disease caused by
diabetes may itself influence the BOLD response during
cognitive tasks. For example, prescan blood glucose may
influence neuronal metabolism as measured by positron
emission tomography (FDG-PET). However, its impact on
BOLD-fMRI activation is less clear. Hypoglycemia-related
changes in activation occur only at very low glucose levels
(2.5mmol) [41], and higher levels (9.6–18.6mmol/L) had a
negligible effect on BOLD activation during a visual stimulus
[42]. The physiological range of blood glucose at screening
in our study (4.6–10mmol/L) and the lack of hypoglycemic
symptoms in our subjects prior to scan suggest a low likeli-
hood for our results to be influenced by prescan glucose, but
we cannot definitively exclude this. We did not have sensitive
imaging measures of white matter microstructural integrity
or beta-amyloid binding or genetic markers of dementia risk
such as apolipoprotein epsilon 4 (ApoE4), and these have
the potential to provide greater mechanistic information and
potentially link AD pathology to the observed differences.
In summary, these results present evidence for dys-
functional neuronal network activity during episodic mem-
ory encoding in type 2 diabetes. The strong control for
genes, age, sex, and early-shared environment in our study
highlights a need to identify potentially modifiable later-
life environmental/lifestyle-related or epigenetic factors that
promote or modify the adverse effect of diabetes on neuronal
health.
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